Global Biomaterial Market (2009-2014) : Market Research Report

Global Biomaterial Market (2009-2014)

Published: Sep. 9, 2009 - 256 Pages

1. CHAPTER ONE: INTRODUCTION
2. Chapter two: Summary
3. Chapter three: Market overview: 3.1. Driving factor analysis of Global biomaterial market; 3.2. Defining the global biomaterial market; 3.3. DEFINING The biomaterial DEVICE MARKET; 3.4. Market drivers of biomaterial market; 3.5. Market inhibitors; 3.6. Opportunities
4. Chapter four: biomaterial product market: 4.1. Orthopedic biomaterial market; 4.2. Cardiovascular; 4.3. Wound care products; 4.4. Urological market; 4.5. Plastic surgery; 4.6. Other biomaterials
5. Chapter five: Biomaterial market: 5.1. Ceramics; 5.2. Metals; 5.3. Polymers
6. Chapter Six: Application market: 6.1. General surgery; 6.2. Surgical Appliances and supplies; 6.3. Drug delivery applications; 6.4. Dental products; 6.5. Surgical and Medical Instruments; 6.6. Electro medical equipment application; 6.7. Other applications
7. Chapter Seven: Geographic Analysis of biomaterial market
8. Chapter eight: Company profiles: 8.1. 3DM, Inc.; 8.2. AdvanSource Biomaterials Corporation; 8.3. Allergan Inc.; 8.4. AlloSource; 8.5. Alphatec Spine, Inc.; 8.6. Amedica Corporation; 8.7. Angiotech Pharmaceuticals, Inc.; 8.8. ApaTech Ltd.; 8.9. Artimplant AB; 8.10. Biocoral, Inc.; 8.11. BioInteractions Ltd.; 8.12. Bioretec Ltd.; 8.13. Bio Syntech Canada Inc.; 8.14. Boston Scientific Corporation; 8.15. Collagen Matrix, Inc.; 8.16. Corin Group PLC; 8.17. Covalon technologies; 8.18. CryoLife Inc.; 8.19. Davol, Inc.; 8.20. Depuy Orthopaedics Inc.; 8.21. ETEX Corporation; 8.22. Forticell Bioscience, Inc.; 8.23. Genzyme Biosurgery; 8.24. Haemacure Corporation; 8.25. Inion Oy; 8.26. Integra Lifesciences Holdings Corp.; 8.27. International Biocomposites Ltd.; 8.28. Invibio Ltd.; 8.29. ISTO Technologies, Inc.; 8.30. Kensey Nash Corporation; 8.31. Medtronic, Inc.; 8.32. Mentor Corporation; 8.33. MIV Therapeutics Inc.; 8.34. Olympus Terumo Biomaterials Ltd.; 8.35. Organogenesis, Inc.; 8.36. Orthovita; 8.37. Osteotech, Inc.; 8.38. Pioneer Surgical Technology; 8.39. Polymer Technology Group; 8.40. Protein Polymer Technologies Inc.; 8.41. RTI Biologics, Inc.; 8.42. Smith & Nephew plc; 8.43. Stryker Corporation; 8.44. Synthes, Inc.; 8.45. TEI Biosciences; 8.46. TORNIER Inc.; 8.47. Vygon S.A; 8.48. W.L. Gore & Associates Inc.; 8.49. Wright Medical Group, Inc.; 8.50. Zimmer Holding, Inc.
9. Chapter nine: Patent analysis
Appendix: 1. U.S. biomaterial product patents; 2. Europe biomaterial product patents; 3. Asia biomaterial product patents; 4. U.S. biomaterial patents; 5. Europe biomaterial patent; 6. Asia biomaterial patents
List of Tables: Summary Table Global biomaterial market, by products 2007 - 2014 ($ million); TABLE 1 GLOBAL orthopedic BIOMATERIAL DEVICE MARKET, BY TYPES 2007 - 2014 ($ million); TABLE 2 GLOBAL orthopedic biomaterial MARKET, BY PRODUCTS 2007 - 2014 ($ million); TABLE 3 GLOBAL orthopedic biomaterial MARKET, BY geography 2007 - 2014 ($ million); TABLE 4 MAJOR PLAYERS AND THEIR RESPECTIVE PRODUCT DEVELOPMENTS; TABLE 5 GLOBAL reconstructive orthopedic BIOMATERIAL DEVICE MARKET, BY TYPES 2007 - 2014 ($ million); TABLE 6 GLOBAL reconstructive orthopedic biomaterial MARKET, BY PRODUCTS 2007 - 2014 ($ million); TABLE 7 GLOBAL reconstructive orthopedic biomaterial MARKET, BY geography 2007 - 2014 ($ million); TABLE 8 MAJOR PLAYERS AND THEIR RESPECTIVE DEVELOPMENTS; TABLE 9 GLOBAL artificial hip orthopedic biomaterial MARKET, BY PRODUCTS 2007 - 2014 ($ million); TABLE 10 GLOBAL artificial hip orthopedic biomaterial MARKET, BY geography 2007 - 2014 ($ million); TABLE 11 GLOBAL cemented prostheses orthopedic biomaterial MARKET, BY geography2007 - 2014 ($ million); TABLE 12 GLOBAL uncemented prostheses orthopedic biomaterial MARKET, BY geography, 2007 - 2014 ($ million); TABLE 13 GLOBAL artificial knee orthopedic biomaterial MARKET, BY PRODUCTS 2007 - 2014 ($ million); TABLE 14 GLOBAL artificial knee orthopedic biomaterial MARKET, BY geography 2007 - 2014 ($ million); TABLE 15 GLOBAL non-constrainT implants orthopedic biomaterial MARKET, BY geography 2007 - 2014 ($ millions); TABLE 16 GLOBAL semi-constrainT orthopedic biomaterials MARKET, BY geography 2007 - 2014 ($ million); TABLE 17 GLOBAL constrainT implants orthopedic biomaterial MARKET, BY geography 2007 - 2014 ($ million); TABLE 18 GLOBAL trauma orthopedic BIOMATERIAL DEVICE MARKET, BY TYPES 2007 - 2014 ($ million); TABLE 19 GLOBAL trauma orthopedic biomaterial MARKET, BY PRODUCTS 2007 - 2014 ($ million); TABLE 20 GLOBAL trauma orthopedic biomaterial MARKET, BY geography 2007 - 2014 ($ million); TABLE 21 MAJOR PLAYERS AND THEIR RESPECTIVE PRODUCT DEVELOPMENTS; TABLE 22 GLOBAL orthobiologics biomaterial MARKET, BY device 2007 - 2014 ($ million); TABLE 23 GLOBAL orthobiologics biomaterial MARKET, BY PRODUCTS 2007 - 2014 ($ million); TABLE 24 GLOBAL orthobiologics biomaterial MARKET, BY geography 2007 - 2014 ($ million); TABLE 25 MAJOR PLAYERS AND THEIR RESPECTIVE DEVELOPMENTS; TABLE 26 GLOBAL DBM orthopedic biomaterial MARKET, BY geography 2007 - 2014 ($ million); TABLE 27 GLOBAL machined bone allograft orthopedic biomaterial MARKET, BY geography 2007 - 2014 ($ million); TABLE 28 GLOBAL non proprietary allograft orthopedic MARKET, BY geography 2007 - 2014 ($ million); TABLE 29 GLOBAL synthetic bone substitute orthopedic biomaterials MARKET, BY geography 2007 - 2014 ($ million); TABLE 30 GLOBAL BMP orthopedic biomaterial MARKET, BY geography 2007 - 2014 ($ million); TABLE 31 GLOBAL platelet concentrates orthopedic biomaterial MARKET, BY geography 2007 - 2014 ($ million); TABLE 32 GLOBAL sports medicine orthopedic biomaterial MARKET, BY geography 2007 - 2014 ($ million); TABLE 33 MAJOR PLAYERS AND THEIR RESPECTIVE PRODUCT DEVELOPMENTS; TABLE 34 GLOBAL bone cement orthopedic biomaterial MARKET, BY geography 2007 - 2014 ($ million); TABLE 35 MAJOR PLAYERS AND THEIR RESPECTIVE PRODUCT DEVELOPMENTS; TABLE 36 GLOBAL spine orthopedic biomaterial MARKET, BY device 2007 - 2014 ($ million); TABLE 37 GLOBAL spine orthopedic biomaterial MARKET, BY PRODUCTS 2007 - 2014 ($ million); TABLE 38 GLOBAL spine orthopedic biomaterial MARKET, BY geography 2007 - 2014 ($ million); TABLE 39 MAJOR PLAYERS AND THEIR RESPECTIVE DEVELOPMENTS; TABLE 40 GLOBAL cervical spine orthopedic biomaterial MARKET, BY PRODUCTS 2007 - 2014 ($ million); TABLE 41 GLOBAL cervical spine orthopedic biomaterial MARKET, BY geography 2007 - 2014 ($ million); TABLE 42 GLOBAL lumbar spine orthopedic biomaterial MARKET, BY PRODUCTS 2007 - 2014 ($ million); TABLE 43 GLOBAL lumbar spine orthopedic biomaterial MARKET, BY geography 2007 - 2014 ($ million); TABLE 44 GLOBAL dental orthopedic BIOMATERIAL DEVICE MARKET, BY TYPES 2007 - 2014 ($ million); TABLE 45 GLOBAL dental orthopedic biomaterial MARKET, BY PRODUCTS 2007 - 2014 ($ million); TABLE 46 GLOBAL dental orthopedic biomaterials MARKET, BY geography 2007 - 2014 ($ million); TABLE 47 MAJOR PLAYERS AND THEIR RESPECTIVE DEVELOPMENTS; TABLE 48 GLOBAL dental bone graft orthopedic biomaterial MARKET, BY PRODUCTS 2007 - 2014 ($ million); TABLE 49 GLOBAL dental bone graft orthopedic biomaterial MARKET, BY geography, 2007 - 2014 ($ million); TABLE 50 GLOBAL dental allograft orthopedic biomaterial MARKET, BY geography, 2007 - 2014 ($ million); TABLE 51 GLOBAL xenograft dental biomaterial MARKET, BY geography, 2007 - 2014 ($ million); TABLE 52 GLOBAL synthetic dental biomaterial MARKET, BY geography 2007 - 2014 ($ million); TABLE 53 GLOBAL tissue regeneration dental biomaterial MARKET, BY geography 2007 - 2014 ($ million); TABLE 54 GLOBAL dental membrane biomaterial MARKET, BY geography 2007 - 2014 ($ million); TABLE 55 GLOBAL cardiovascular biomaterial MARKET, BY PRODUCTS 2007 - 2014 ($ million); TABLE 56 GLOBAL cardiovascular biomaterial MARKET, BY PRODUCTS 2007 - 2014 ($ million); TABLE 57 GLOBAL cardiovascular biomaterial MARKET, BY geography 2007 - 2014 ($ million); TABLE 58 MAJOR PLAYERS AND THEIR RESPECTIVE DEVELOPMENTS; TABLE 59 GLOBAL cardiac pacemaker cardiovascular device MARKET, BY geography 2007 - 2014 ($ million); TABLE 60 MAJOR PLAYERS AND THEIR RESPECTIVE PRODUCT DEVELOPMENTS; TABLE 61 GLOBAL implantable cardioverter defibrillator cardiovascular biomaterial MARKET, BY geography 2007 - 2014 ($ million); TABLE 62 MAJOR PLAYERS AND THEIR RESPECTIVE PRODUCT DEVELOPMENTS; TABLE 63 GLOBAL cardiac stents cardiovascular biomaterial MARKET, BY PRODUCTS 2007 - 2014 ($ million); TABLE 64 GLOBAL cardiac stents cardiovascular biomaterial MARKET, BY geography 2007 - 2014 ($ million); TABLE 65 MAJOR PLAYERS AND THEIR RESPECTIVE PRODUCT DEVELOPMENTS; TABLE 66 GLOBAL artificial heart valve cardiovascular biomaterial MARKET, BY PRODUCTS 2007 - 2014 ($ million); TABLE 67 GLOBAL artificial heart valve cardiovascular biomaterial MARKET, BY geography 2007 - 2014 ($ million); TABLE 68 MAJOR PLAYERS AND THEIR RESPECTIVE DEVELOPMENTS; TABLE 69 GLOBAL vascular access devices cardiovascular biomaterial MARKET, BY PRODUCTS 2007 - 2014 ($ million); TABLE 70 GLOBAL vascular access devices cardiovascular biomaterial MARKET, BY geography 2007 - 2014 ($ million); TABLE 71 MAJOR PLAYERS AND THEIR RESPECTIVE DEVELOPMENTS; TABLE 72 GLOBAL peripheral vascular grafts MARKET, BY geography 2007 - 2014 ($ million); TABLE 73 GLOBAL wound care BIOMATERIAL DEVICE MARKET, BY TYPES 2007 - 2014 ($ million); TABLE 74 GLOBAL wound care biomaterial MARKET, BY PRODUCTS, 2007 - 2014 ($ million); TABLE 75 GLOBAL wound care biomaterial MARKET, BY geography2007 - 2014 ($ million); TABLE 76 MAJOR PLAYERS AND THEIR RESPECTIVE PRODUCT DEVELOPMENTS; TABLE 77 GLOBAL internal tissue sealant wound care biomaterial MARKET, BY PRODUCTS, 2007 - 2014 ($ million); TABLE 78 GLOBAL internal tissue sealant wound care biomaterial MARKET, BY geography 2007 - 2014 ($ million); TABLE 79 MAJOR PLAYERS AND THEIR RESPECTIVE PRODUCT DEVELOPMENTS; TABLE 80 GLOBAL fibrin-based sealant wound care biomaterial MARKET, BY geography 2007 - 2014 ($ million); TABLE 81 GLOBAL synthetic based sealant wound care biomaterial MARKET, BY geography 2007 - 2014 ($ million); TABLE 82 GLOBAL surgical hemostats wound care biomaterial MARKET, BY PRODUCTS 2007 - 2014 ($ million); TABLE 83 GLOBAL surgical hemostats wound care biomaterial MARKET, BY geography 2007 - 2014 ($ million); TABLE 84 MAJOR PLAYERS AND THEIR RESPECTIVE PRODUCT DEVELOPMENTS; TABLE 85 GLOBAL thrombin based hemostats wound care biomaterial MARKET, BY geography 2007 - 2014 ($ million); TABLE 86 GLOBAL oxidized regenerated cellulose based hemostats wound care biomaterial MARKET, BY geography 2007 - 2014 ($ million); TABLE 87 GLOBAL gelatin based hemostats wound care biomaterial MARKET, BY geography 2007 - 2014 ($ million); TABLE 88 GLOBAL combination hemostats wound care biomaterial MARKET, BY geography 2007 - 2014 ($ million); TABLE 89 GLOBAL collagen based hemostats wound care biomaterial MARKET, BY geography 2007 - 2014 ($ million); TABLE 90 GLOBAL autologous based hemostats wound care biomaterial MARKET, BY geography 2007 - 2014 ($ million); TABLE 91 GLOBAL polysaccharide based hemostats wound care biomaterial MARKET, BY geography 2007 - 2014 ($ million); TABLE 92 GLOBAL adhesion barriers wound care MARKET, BY PRODUCTS 2007 - 2014 ($ million); TABLE 93 GLOBAL adhesion barriers wound care MARKET, BY geography 2007 - 2014 ($ million); TABLE 94 MAJOR PLAYERS AND THEIR RESPECTIVE DEVELOPMENTS; TABLE 95 GLOBAL films wound care biomaterial MARKET, BY geography 2007 - 2014 ($ million); TABLE 96 GLOBAL gels wound care biomaterial MARKET, BY geography 2007 - 2014 ($ million); TABLE 97 GLOBAL skin substitute wound care biomaterial MARKET, BY geography 2007 - 2014 ($ million); TABLE 98 GLOBAL gastrointestinal biomaterial MARKET, BY geography 2007 - 2014 ($ million); TABLE 99 MAJOR PLAYERS AND THEIR RESPECTIVE DEVELOPMENTS; TABLE 100 GLOBAL urological BIOMATERIAL DEVICE MARKET, BY TYPES 2007 - 2014 ($ million); TABLE 101 GLOBAL urological biomaterial MARKET, BY PRODUCTS 2007 - 2014 ($ million); TABLE 102 GLOBAL urological biomaterial MARKET, BY geography 2007 - 2014 ($ million); TABLE 103 MAJOR PLAYERS AND THEIR RESPECTIVE DEVELOPMENTS; TABLE 104 GLOBAL stents urological biomaterial MARKET, BY geography 2007 - 2014 ($ million); TABLE 105 GLOBAL catheter urological biomaterial MARKET, BY PRODUCTS 2007 - 2014 ($ million); TABLE 106 GLOBAL catheters urological biomaterial MARKET, BY geography 2007 - 2014 ($ million); TABLE 107 GLOBAL dialysis catheter urological BIOMATERIAL DEVICE MARKET, BY TYPES 2007 - 2014 ($ million); TABLE 108 GLOBAL dialysis catheter urological biomaterial MARKET, BY PRODUCTS 2007 - 2014 ($ million); TABLE 109 GLOBAL dialysis catheter urological biomaterial MARKET, BY geography 2007 - 2014 ($ million); TABLE 110 MAJOR PLAYERS AND THEIR RESPECTIVE PRODUCT DEVELOPMENTS; TABLE 111 GLOBAL hemodialysis catheter urological biomaterial MARKET, BY geography 2007 - 2014 ($ million); TABLE 112 GLOBAL peritonial catheter urological biomaterial MARKET, BY geography 2007 - 2014 ($ million); TABLE 113 GLOBAL urinary catheter urological BIOMATERIAL DEVICE MARKET, BY TYPES 2007 - 2014 ($ million); TABLE 114 GLOBAL urinary catheter urological biomaterial MARKET, BY PRODUCTS 2007 - 2014 ($ million); TABLE 115 GLOBAL urinary catheters urological biomaterial MARKET, BY geography 2007 - 2014 ($ million); TABLE 116 GLOBAL indwelling catheter urological biomaterial MARKET, BY geography 2007 - 2014 ($ million); TABLE 117 GLOBAL plastic surgery biomaterial device MARKET, BY types 2007 - 2014 ($ million); TABLE 118 GLOBAL plastic surgery biomaterial MARKET, BY PRODUCTS 2007 - 2014 ($ million); TABLE 119 GLOBAL plastic surgery biomaterial MARKET, BY geography 2007 - 2014 ($ million); TABLE 120 MAJOR PLAYERS AND THEIR RESPECTIVE PRODUCT DEVELOPMENTS; TABLE 121 GLOBAL breast implants plastic surgery BIOMATERIAL DEVICE MARKET, BY TYPES 2007 - 2014 ($ million); TABLE 122 GLOBAL breast implants plastic surgery biomaterial MARKET, BY PRODUCTS 2007 - 2014 ($ million); TABLE 123 GLOBAL breast implants plastic surgery biomaterial MARKET, BY geography 2007 - 2014 ($ million); TABLE 124 MAJOR PLAYERS AND THEIR RESPECTIVE DEVELOPMENTS; TABLE 125 GLOBAL saline filled implants breast implant biomaterial MARKET, BY geography 2007 - 2014 ($ million); TABLE 126 GLOBAL silicone gel implants breast implant biomaterial MARKET, BY geography 2007 - 2014 ($ million); TABLE 127 GLOBAL injectable fillers breast implant biomaterial MARKET, BY geography 2007 - 2014 ($ million); TABLE 128 MAJOR PLAYERS AND THEIR RESPECTIVE PRODUCT DEVELOPMENTS; TABLE 129 GLOBAL facial implants plastic surgery biomaterial MARKET, BY geography 2007 - 2014 ($ million); TABLE 130 MAJOR PLAYERS AND THEIR RESPECTIVE DEVELOPMENTS; TABLE 131 GLOBAL biomaterial MARKET, BY types 2007 - 2014 ($ million); TABLE 132 GLOBAL ceramics MARKET, BY types of biomaterials 2007 - 2014 ($ million); TABLE 133 MAJOR PLAYERS AND THEIR RESPECTIVE DEVELOPMENTS; Table 134 Technological advancements in ceramics market; TABLE 135 GLOBAL bioinert ceramics MARKET, BY types of biomaterials 2007 - 2014 ($ million); TABLE 136 GLOBAL bioactive ceramics MARKET, BY types 2007 - 2014 ($ million); TABLE 137 GLOBAL biodegradable ceramics MARKET, BY types 2007 - 2014 ($ million); TABLE 138 GLOBAL metallic biomaterial MARKET, BY types 2007 - 2014 ($ million); TABLE 139 MAJOR PLAYERS AND THEIR RESPECTIVE PRODUCT DEVELOPMENTS; TABLE 140 GLOBAL pure form metals MARKET, BY types 2007 - 2014 ($ million); TABLE 141 GLOBAL alloy biomaterial MARKET, BY types 2007 - 2014 ($ million); TABLE 142 MAJOR PLAYERS AND THEIR RESPECTIVE PRODUCT DEVELOPMENTS; TABLE 143 GLOBAL polymer biomaterials MARKET, BY types 2007 - 2014 ($ million); TABLE 144 MAJOR PLAYERS AND THEIR RESPECTIVE PRODUCT DEVELOPMENTS; TABLE 145 GLOBAL natural polymer biomaterial MARKET, BY types 2007 - 2014 ($ million); TABLE 146 GLOBAL synthetic polymer biomaterial MARKET, BY types of biomaterials 2007 - 2014 ($ million); TABLE 147 Application market for biomaterials; TABLE 148 Global biomaterial market, by geography, 2007 - 2014 ($ million); TABLE 149 U.S. biomaterial market, by products, 2007 - 2014($ million); TABLE 150 European biomaterial market, by products, 2007 - 2014 ($ million); TABLE 151 Asian biomaterial market, by products, 2007 - 2014 ($ million); TABLE 152 3dm, inc. Product profile; TABLE 153 3dm, inc. strategy; TABLE 154 AdvanSource Biomaterials Corporation product profile; TABLE 155 allergan inc. Product profile; TABLE 156 allosource Product profile; TABLE 157 allosource strategy; TABLE 158 Alphatec Spine, Inc. Product profile; TABLE 159 Alphatec Spine, Inc. strategies and developments; TABLE 160 amedica corporation Product profile; TABLE 161 amedica corporation Developments; TABLE 162 Angiotech pharmaceuticals, Inc. Product profile; TABLE 163 Angiotech pharmaceuticals, Inc. Strategy; TABLE 164 apatech ltd. Product profile; TABLE 165 artimplant ab product profile; TABLE 166 artimplant ab strategies and developments; TABLE 167 Biointeractions Ltd. product profile; TABLE 168 bioretec ltd. product profile; TABLE 169 bio syntech canada inc. product profile; TABLE 170 bio syntech canada inc. Strategy; TABLE 171 Boston scientific CORPORATION PRODUCT profile; TABLE 172 Collagen matrix, Inc. Product profile; TABLE 173 Collagen matrix, Inc. Strategy; TABLE 174 Corin group, plc. Product profile; TABLE 175 Covalon technologies Product profile; TABLE 176 Covalon strategy; TABLE 177 CryoLife Inc, Product Profile; TABLE 178 CryoLife Inc., strategy; TABLE 179 davol, Inc. Product profile; TABLE 180 davol, Inc. Strategy; TABLE 181 DePuy Orthopedics, Inc. Product profile; TABLE 182 DePuy Orthopedics, Inc. Strategy; TABLE 183 etex corporation Product profile; TABLE 184 Etex corporation strategies and developments; TABLE 185 Genzyme Biosurgery Product profile; TABLE 186 Genzyme Biosurgery Developments; TABLE 187 nion oy Product profile; TABLE 188 ntegra Life sciences Holdings Corp. product profile; TABLE 189 ntegra Life sciences Holdings Corp. strategy; TABLE 190 International Biocomposites ltd. Product profile; TABLE 191 International Biocomposites ltd. Developments; TABLE 192 invibio ltd. Product profile; TABLE 193 invibio ltd. strategy; TABLE 194 isto technologies, inc. applications; TABLE 195 Kensey Nash corporation Product profile; TABLE 196 medtronic Inc. Product Profile; TABLE 197 Medtronic inc. strategies & developments; TABLE 198 mentor corporation Product profile; TABLE 199 MIV Therapeutics Inc. Product Profile; TABLE 200 Olympus Terumo product profile; TABLE 201 Olympus Terumo Strategy; TABLE 202 organogenesis, Inc. Product profile; TABLE 203 orthovita product profile; TABLE 204 osteotech, Inc. Product profile; TABLE 205 Pioneer Surgical Technology Product profile; TABLE 206 Pioneer Surgical Technology strategy; TABLE 207 Polymer Technology Group profile; TABLE 208 Protein polymer technologies, Inc. Product profile; TABLE 209 RTI biologics product profile; TABLE 210 RTI biologics Strategies; TABLE 211 smith & nephew plc Product profile; TABLE 212 smith & nephew plc strategy; TABLE 213 Stryker Corporation product profile; TABLE 214 Synthes inc. product profile; TABLE 215 Synthes inc. Strategy; TABLE 216 Tei biosciences Product profile; TABLE 217 tornier inc. product profile; TABLE 218 tornier inc. strategy; TABLE 219 vygon s.a Product profile; TABLE 220 vygon s.a strategy; TABLE 221 W.L. Gore & Associates Inc. Product profile; TABLE 222 Wright medical group, inc. product profile; TABLE 223 Wright medical group, inc. Developments; TABLE 224 zimmer holdings, inc. Product profile; TABLE 225 zimmer holdings, inc. strategy
List of Figures: Figure 1 Evolution of biomaterials; Figure 2 PARENTAL STRUCTURE OF biomaterials; Figure 3 Characteristics of biomaterial science; Figure 4 Factors affecting the biomaterial market; Figure 5 Global biomaterial device market, by product (2009); Figure 6 relative potential matrix for biomaterial products market (2014); Figure 7 Increasing Disability with age; Figure 8 Increasing World’s aging population; Figure 9 Geographical analysis of Biomaterial market (2009); Figure 10 Biomaterials patents, by geography; Figure 11 Biomaterials patents in 2006, by geography; Figure 12 Biomaterials patents in 2008 by geography
LIST OF ACRONYMS AND ABBREVIATIONS: 1. AAOS: American Academy of Orthopedic Surgery; 2. AF: Atrial Fibrillation; 3. BMP: Bone Morphogenic Protein; 4. BTB: Bone Tendon Bone; 5. CAGR: Compounded Annual Growth Rate; 6. CE: Conformité Européene; 7. CP: Combination Pharmacotherapy; 8. CMF: Craniomaxillofacial; 9. CRT: Cardiac Resynchronization Therapy; 10. CSC: Cancellous Structure Ceramics; 11. CT: Computed Tomography; 12. DBM: Demineralized Bone Matrix; 13. DES: Drug Eluting Stents; 14. ESC: Environmental Stress Cracking; 15. FDA: Food and Drugs Administration; 16. HA: Hyaluronic Acid; 17. ICD: Implantable Cardioverter Defibrillator; 18. IDE: Investigational Device Exemption; 19. LCP: Locking Compression Plate; 20. MI: Myocardial Infraction; 21. MRI: Magnetic Resonance Imaging; 22. MIS: Minimally Invasive Surgery; 23. MS: Multiple Sclerosis; 24. OTC: Over the Counter; 25. PEEK: Polyetheretherketone; 26. PICC: Peripherally Inserted Central Catheter; 27. PMMA: Polymethylmethacrylate; 28. R&D: Research and Development; 29. RF: Radio Frequency; 30. ROW: Rest of the World; 31. SFDA: State Food and Drugs Administration

Abstract

Report Description

The biomaterials market is defined and explained through the introduction of biotechnology and advances in the understanding of human tissue compatibility. Developing from bio-inert materials to biodegradable materials, biomaterials are widely used in medical devices, tissue replacement, and surface coating applications. The major segments in biomaterials market are ceramics, metals, polymers, and composites. Biomaterials products are classified into orthopedic, cardiovascular, gastrointestinal, wound care, urology, plastic surgery, and others. Reconstructive surgery and orthobiologics are the dominant segments in orthopedic biomaterials market.

Biomaterials products had a market size of $25.5 billion in 2008, and the biomaterial device market size was $115.4 billion in the same year, and is expected to reach $252.7 billion in 2014. This massive revenue potential highlights the immense opportunity in the market. In the next five years, the biomaterials market is expected to grow at a CAGR of 15%.

Improved patient benefits form the most important factor stimulating market growth for biomaterials. The other market drivers are increase in aging population, rising awareness, shorter product approval time, and larger application area. However, the lack of tissue availability and proper reimbursement facilities are restraining the growth of the biomaterials market.

Improvement in fabrication technology and new product development at competitive prices will be the key to future market growth. The U.S. and Europe hold a major share of the global biomaterials market; while emerging economies such as China, India, Japan, Brazil, Russia, and Romania represent a high growth rate.

REPORT DESCRIPTION

This report uses the term biomaterials to refer to the materials used in the human body. The report segments the global biomaterial market as follows:

Biomaterials product market Orthopaedic, cardiovascular, gastrointestinal, wound care, plastic surgery, urological and others
Biomaterials ingredient market Metals, polymers, ceramics, composites
Biomaterials application market General, surgical appliances and supplies, surgical and medical instruments, dental products, electro-medical equipment, in-vitro diagnostic products, and other applications

Each section will provide market data, market drivers, trends and opportunities, top-selling products, key players, and competitive outlook. This report will also provide more than 100 market tables for various geographic regions covering the sub-segments and micro-markets. In addition, the report also provides more than 50 company profiles for each of its sub-segments.

What makes our reports unique?

We provide the longest market segmentation chain in this industry- not many reports provide market breakdown upto level 5.
Each report is about 250 pages with 100+ market data tables, 40 competitive company profiles, analysis of 300 patents and a minimum of 50 micro markets, which are collectively exhaustive and mutually exclusive.
No single report by any other publisher provides market data for all the segments viz products, services, applications, ingredients, technology, and stakeholders in a single report for all the four geographies - US, Europe, APAC, ROW.
We provide 10% customization. Normally it is seen that clients do not find specific market intelligence that they are looking for. Our customization will ensure that you necessarily get the market intelligence you are looking for and we get a loyal customer.
15 pages of high level analysis including benchmarking strategies, best practices and the market’s cash cows (BCG matrix). We conduct detailed market positioning, product positioning and competitive positioning. Entry strategies, gaps and opportunities are identified for all the stakeholders.
Comprehensive market analysis for the following sectors: Pharmaceuticals, Medical Devices, Biotechnology, Semiconductor and Electronics, Energy and Power Supplies, Food and Beverages, Chemicals, Advanced Materials, Industrial Automation, and Telecom and IT. We also analyze retailers and super-retailers, technology providers, and research and development (R&D) companies.

Key questions answered

Which are the high-growth segments/cash cows and how is the market segmented in terms of applications, products, services, ingredients, technologies, and stakeholders?
What are market estimates and forecasts; which markets are doing well and which are not?
Where are the gaps and opportunities; what is driving the market?
Which are the key playing fields? Which are the winning edge imperatives?
How is the competitive outlook; who are the main players in each of the segments; what are the key selling products; what are their strategic directives, operational strengths and product pipelines? Who is doing what?

Powerful Research and analysis

The analysts working with MarketsandMarkets come from renowned publishers and market research firms, globally, adding their expertise and domain understanding. We get the facts from over 22,000 news and information sources, a huge database of key industry participants and draw on our relationships with more than 900 market research companies across the world. We, at MarketsandMarkets, are inspired to help our clients grow by providing qualitative business insights with our huge market intelligence repository.

Get Full Details About This Report >>

US: 800.298.5699

Int'l: +1.240.747.3093

About MarketResearch.com
MarketResearch.com is an online aggregator selling over 250,000 market research reports, company profiles and country profiles from over 650 research firms. Our reports will provide you with the critical business and competitive intelligence you need for strategic planning and marketing research. Coverage includes the US, UK, Europe, Asia and global markets.

Global Biomaterial Market (2009-2014)

Table of Contents

Abstract